cbdMD, Inc. Form 8-K Summary
Business Context and Reporting Period
cbdMD, Inc., an emerging growth company incorporated in North Carolina, filed this Current Report on Form 8-K on August 12, 2020. The filing serves to announce the company's financial and operating results for the third fiscal quarter of 2020.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No specific material changes or comparative data versus the prior period are detailed in the body of this Form 8-K. The document solely acts as a notification that the third-quarter results have been issued.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, and contingencies are not present in this filing text. The report explicitly states that the information in Item 7.01 and its exhibits is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 12, 2020) for actual revenue, net income, and cash flow figures for Q3 2020.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbols for Common Stock (YCBD) and 8.0% Series A Cumulative Convertible Preferred Stock (YCBD PR A) on the NYSE American.
- Check subsequent filings for any updates to the financial data referenced in this 8-K.